Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer

Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms

(2010) Ingegerd Hellstrom et al.   CANCER LETTERS

Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women

(2010) Emanuela Anastasi et al.   TUMOR BIOLOGY

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

(2009) K Huhtinen et al.   BRITISH JOURNAL OF CANCER

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Influence of Ovarian Cancer Risk Status on the Diagnostic Performance of the Serum Biomarkers Mesothelin, HE4, and CA125

(2009) C. A. Shah et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The utility of serum human epididymis protein 4 (HE4) in patients with a pelvic mass

(2009) Martina Montagnana et al.   JOURNAL OF CLINICAL LABORATORY ANALYSIS

Effects of Personal Characteristics on Serum CA125, Mesothelin, and HE4 Levels in Healthy Postmenopausal Women at High-Risk for Ovarian Cancer

(2008) K. A. Lowe et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Use of Yeast-Secreted In vivo Biotinylated Recombinant Antibodies (Biobodies) in Bead-Based ELISA

(2008) N. Scholler et al.   CLINICAL CANCER RESEARCH

Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

(2008) Martin Köbel et al.   PLOS MEDICINE

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass

(2007) Richard G. Moore et al.   GYNECOLOGIC ONCOLOGY

A randomized study of screening for ovarian cancer: a multicenter study in Japan

(2007) H. KOBAYASHI et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER